Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

RARE

+ Watchlist+ Portfolio

Ultragenyx Pharmaceutical Inc.

Regulated industryPhysical productsTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$16.70
52-Week Range
$12.73 – $39.89
Market Cap
$1.81B
P/E (TTM)
—
EPS (TTM)
-5.17
Dividend Yield
0.00%
Advanced Metrics
Price/Book
—
PEG Ratio
—
Return on Equity
—
Return on Assets
-22.98%
Gross Margin
-10.69%
Operating Margin
-59.86%
Profit Margin
-71.78%
Current Ratio
1.40
Debt/Equity
—
Total Debt
$1.19B
Free Cash Flow
$-179.38M
Revenue Growth
8.10%
Earnings Growth
—
Enterprise Value
$2.73B

Market Snapshot

About

Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and ultra-rare genetic diseases, with approved treatments for metabolic and bone disorders.